The risk of suicide may increase at the beginning of antidepressant use. Therefore, all patients must be revised two weeks after the start of pharmacological treatment with antidepressants.
Treatment
Pharmacological treatment
Pharmacological treatment, although there are no randomized or placebo-controlled studies, has good evidence of pharmacotherapy effectiveness. Pharmacological treatment is conducted in the following ways: women who are not breastfeeding and those that are breastfeeding. Click on the tabs below to continue reading.
Women who are breastfeeding
The benefits of breastfeeding generally overcome the relatively small risks of psychotropic medications such as antidepressants. However, there are no randomized clinical trials in this area. The evidence on the safety of breastfeeding while using medications come from database of some agencies, case studies and laboratory reports.
Women who are not breastfeeding
It is made use of the same criteria of treatment of non-puerperal depression. If postpartum depression is a recurrence of a previous depression, one should resume using the medication previously used if it was effective and well tolerated. A large number of clinical studies and systematic reviews have concluded that clinical results, quality of life and costs have not yet produced clear evidence to produce clinical protocols for the choice of antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), tricyclic or heterocyclic.